Crossmark

Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database

Crossref DOI link: https://doi.org/10.1186/s12879-019-4129-6

Published Online: 2019-06-10

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ruzicka, Daniel J.

Kuroishi, Naho

Oshima, Nobuyuki

Sakuma, Ryuta

Naito, Toshio
Funding

Funding for this research was provided by:

MSD K.K. (NA)
License Information

Text and Data Mining valid from 2019-06-10

Version of Record valid from 2019-06-10
More Information

Article History

Received: 13 March 2019

Accepted: 23 May 2019

First Online: 10 June 2019

Ethics approval and consent to participate

: Approval from an ethical committee was not required for an observational study using de-identified secondary data according to the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects (). Obtaining consent does not apply to studies using such anonymized data in the Ethical Guidelines. As the data were obtained from Medical Data Vision, Co., Ltd. (MDV), a commercial database provider, no administrative permission was required to access the data.

: Not applicable due to the reason addressed in the ethics approval and consent to participate.

: DJR, NK, and NO are employees and RS was an employee of MSD K.K., Tokyo, Japan. TN has received no funding for this study but received lecture fees from MSD K.K., Tokyo, Japan.

Document is current

Any future updates will be listed below